Article
Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA
14 Sept 2023
Abstract excerpt
Diagnosing post-transplant lymphoproliferative disorder (PTLD) is challenging and often requires invasive procedures. Analyses of cell-free DNA (cfDNA) isolated from plasma is minimally invasive and highly effective for genomic profiling of tumors. We studied the feasibility of using cfDNA to profile PTLD and explore its potential to serve as a screening tool. We included seventeen patients with monomorphic PTLD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
